Clinical Trials

Our clinic trial news comes directly from the U.S. National Institutes of Health.   If you have additional trial information please post it to our website or let us know by email.

Answer ALS: Individualized Initiative for ALS Discovery

Conditions:   Amyotrophic Lateral Sclerosis;   Primary Lateral Sclerosis;   Flail Arm ALS;   Progressive Muscular Atrophy;   Monomelic Amyotrophy;   Motor Neuron Disease;   Asymptomatic ALS Gene Carriers
Intervention:  
Sponsors:   Johns Hopkins University;   Massachusetts General Hospital;   Emory University;   Ohio State University;   Washington University School of Medicine;   Cedars-Sinai Medical Center;   University of California, Irvine;   Massachusetts Institute of Technology;   New York Genome Center;   Leandro P. Rizzuto Foundation

Imaging Biomarkers in ALS

Conditions:   Amyotrophic Lateral Sclerosis;   Primary Lateral Sclerosis
Intervention:  
Sponsor:   University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting - verified November 2016

Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Intervention:   Drug: [18F] GE-180
Sponsors:   Massachusetts General Hospital;   The Methodist Hospital System;   Cedars-Sinai Medical Center;   ALS Association
Recruiting - verified September 2016

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

Conditions:   Graft Failure;   Death;   Acute Rejection of Renal Transplant;   Infections;   Bone Disease;   Post Transplant Diabetes Mellitus;   Quality of Life;   HLA Antibody Production;   Cardiovascular Risk Factors;   Non-HLA Antibody Production
Intervention:   Drug: Tacrolimus once daily (Advagraf)
Sponsors:   Klemens Budde;   Dr. med. univ. L. J. Lehner;   Koordinierungszentrum Klinischer Studie der Charite Berlin (KKS Berlin);   ERA-EDTA;   DESCARTES working group on transplantation;   EKITA (European Kidney Transplant Association)

Pages